Valacyclovir Hydrochloride



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 38.4%
Herpes Zoster 11.2%
Genital Herpes 7.3%
Prophylaxis 6.8%
Herpes Virus Infection 5.6%
Oral Herpes 5.4%
Chemotherapy 3.6%
Antiviral Prophylaxis 2.4%
Herpes Simplex 2.4%
Acute Leukaemia 1.9%
Pain 1.9%
Lymphoma 1.7%
Multiple Myeloma 1.7%
Coronary Artery Bypass 1.5%
Drug Use For Unknown Indication 1.5%
Graft Versus Host Disease 1.5%
Herpes Ophthalmic 1.5%
Hypertension 1.5%
Hiv Infection 1.2%
Chronic Lymphocytic Leukaemia 1.0%
Drug Ineffective 18.2%
Product Substitution Issue 11.8%
Herpes Virus Infection 7.3%
Confusional State 4.5%
Pruritus 4.5%
Pyrexia 4.5%
Therapeutic Response Unexpected With Drug Substitution 4.5%
Toxic Epidermal Necrolysis 4.5%
Agranulocytosis 3.6%
Dizziness 3.6%
Headache 3.6%
Neurotoxicity 3.6%
Oral Herpes 3.6%
Rash Generalised 3.6%
Thrombocytopenia 3.6%
Vomiting 3.6%
Diarrhoea 2.7%
Drug Rash With Eosinophilia And Systemic Symptoms 2.7%
Dysgeusia 2.7%
Nausea 2.7%
Secondary
Product Used For Unknown Indication 31.9%
Acute Lymphocytic Leukaemia 10.2%
Herpes Zoster 7.2%
Chronic Lymphocytic Leukaemia 4.9%
Hiv Infection 4.7%
Antifungal Prophylaxis 4.5%
Genital Herpes 4.1%
Pyrexia 4.1%
Lung Disorder 3.7%
Hypertension 3.5%
Multiple Myeloma 3.5%
Breast Cancer 2.9%
Depression 2.7%
Acute Leukaemia 2.5%
Prophylaxis 2.2%
Chronic Myeloid Leukaemia 1.6%
Pain 1.6%
Antiviral Prophylaxis 1.4%
Herpes Virus Infection 1.4%
Oral Herpes 1.4%
Renal Failure 8.0%
Contusion 6.9%
Drug Ineffective 6.9%
Hepatitis Cholestatic 6.9%
Photosensitivity Reaction 6.9%
Pollakiuria 6.9%
Confusional State 5.7%
Renal Failure Acute 5.7%
Toxic Epidermal Necrolysis 5.7%
Drug Eruption 4.6%
Herpes Virus Infection 4.6%
Toxic Optic Neuropathy 4.6%
Acute Hepatic Failure 3.4%
Aplasia 3.4%
Eosinophilia 3.4%
Erythema Multiforme 3.4%
Muscle Spasms 3.4%
Thrombocytopenia 3.4%
Vomiting 3.4%
Cataract 2.3%
Concomitant
Product Used For Unknown Indication 22.7%
Prophylaxis 14.3%
Diffuse Large B-cell Lymphoma 9.8%
Multiple Myeloma 7.6%
Infection Prophylaxis 5.0%
Hiv Infection 4.7%
B-cell Lymphoma 3.7%
Aplastic Anaemia 3.6%
Premedication 3.5%
Chronic Lymphocytic Leukaemia 3.2%
Mantle Cell Lymphoma 3.0%
Antiviral Prophylaxis 2.7%
Antifungal Prophylaxis 2.5%
Bone Marrow Conditioning Regimen 2.5%
Hypertension 2.5%
Pain 2.1%
Acute Myeloid Leukaemia 1.9%
Constipation 1.8%
Antibiotic Prophylaxis 1.5%
Prophylaxis Against Graft Versus Host Disease 1.5%
Pneumonia 9.8%
Infection 8.3%
Pyrexia 7.3%
Myelodysplastic Syndrome 5.9%
Febrile Bone Marrow Aplasia 5.4%
Pancytopenia 5.4%
Thrombocytopenia 5.4%
Febrile Neutropenia 4.9%
Lung Disorder 4.9%
Sepsis 4.9%
Cytolytic Hepatitis 4.4%
Herpes Simplex 4.4%
Vomiting 4.4%
Weight Decreased 4.4%
Anaemia 3.4%
Diarrhoea 3.4%
Drug Rash With Eosinophilia And Systemic Symptoms 3.4%
Electrocardiogram Qt Prolonged 3.4%
Neuropathy Peripheral 3.4%
Renal Failure 3.4%
Interacting
Headache 50.0%
Depression 25.0%
Genital Herpes 25.0%
Drug Interaction 100.0%